annual EBIT:
-$72.60M+$74.72M(+50.72%)Summary
- As of today (June 1, 2025), MIRM annual earnings before interest & taxes is -$72.60 million, with the most recent change of +$74.72 million (+50.72%) on December 31, 2024.
- During the last 3 years, MIRM annual EBIT has fallen by -$6.24 million (-9.40%).
- MIRM annual EBIT is now -38.20% below its all-time high of -$52.53 million, reached on December 31, 2019.
Performance
MIRM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$10.05M+$10.73M(+51.64%)Summary
- As of today (June 1, 2025), MIRM quarterly earnings before interest & taxes is -$10.05 million, with the most recent change of +$10.73 million (+51.64%) on March 31, 2025.
- Over the past year, MIRM quarterly EBIT has increased by +$11.03 million (+52.31%).
- MIRM quarterly EBIT is now -116.39% below its all-time high of $61.32 million, reached on December 31, 2021.
Performance
MIRM quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$61.58M+$11.03M(+15.19%)Summary
- As of today (June 1, 2025), MIRM TTM earnings before interest & taxes is -$61.58 million, with the most recent change of +$11.03 million (+15.19%) on March 31, 2025.
- Over the past year, MIRM TTM EBIT has increased by +$81.14 million (+56.85%).
- MIRM TTM EBIT is now -94630.77% below its all-time high of -$65.00 thousand, reached on September 30, 2018.
Performance
MIRM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MIRM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +50.7% | +52.3% | +56.9% |
| 3 y3 years | -9.4% | +69.4% | -18.3% |
| 5 y5 years | -38.2% | +52.8% | +9.0% |
MIRM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -9.4% | +50.7% | at high | +85.6% | -87.5% | +61.4% |
| 5 y | 5-year | -38.2% | +50.7% | -116.4% | +85.6% | -87.5% | +62.6% |
| alltime | all time | -38.2% | +50.7% | -116.4% | +85.6% | <-9999.0% | +62.6% |
MIRM EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$10.05M(-51.6%) | -$61.58M(-15.2%) |
| Dec 2024 | -$72.60M(-50.7%) | -$20.79M(+101.8%) | -$72.60M(-13.2%) |
| Sep 2024 | - | -$10.30M(-49.6%) | -$83.69M(-10.2%) |
| Jun 2024 | - | -$20.43M(-3.1%) | -$93.15M(-34.7%) |
| Mar 2024 | - | -$21.08M(-33.9%) | -$142.71M(-3.1%) |
| Dec 2023 | -$147.32M(+16.8%) | -$31.87M(+61.2%) | -$147.32M(-0.0%) |
| Sep 2023 | - | -$19.77M(-71.8%) | -$147.38M(-7.5%) |
| Jun 2023 | - | -$70.00M(+172.5%) | -$159.34M(+33.9%) |
| Mar 2023 | - | -$25.69M(-19.6%) | -$118.96M(-5.7%) |
| Dec 2022 | -$126.09M(+90.0%) | -$31.93M(+0.7%) | -$126.09M(+284.0%) |
| Sep 2022 | - | -$31.72M(+7.1%) | -$32.84M(-22.8%) |
| Jun 2022 | - | -$29.62M(-9.8%) | -$42.55M(-18.2%) |
| Mar 2022 | - | -$32.82M(-153.5%) | -$52.04M(-21.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$66.36M(-35.5%) | $61.32M(-248.0%) | -$66.36M(-59.7%) |
| Sep 2021 | - | -$41.43M(+5.9%) | -$164.55M(+13.8%) |
| Jun 2021 | - | -$39.11M(-17.1%) | -$144.63M(+12.3%) |
| Mar 2021 | - | -$47.15M(+27.9%) | -$128.77M(+25.1%) |
| Dec 2020 | -$102.93M(+95.9%) | -$36.87M(+71.4%) | -$102.93M(+24.7%) |
| Sep 2020 | - | -$21.51M(-7.5%) | -$82.51M(+7.3%) |
| Jun 2020 | - | -$23.25M(+9.1%) | -$76.87M(+13.6%) |
| Mar 2020 | - | -$21.31M(+29.5%) | -$67.65M(+28.8%) |
| Dec 2019 | -$52.53M | -$16.45M(+3.7%) | -$52.53M(+45.6%) |
| Sep 2019 | - | -$15.87M(+13.1%) | -$36.09M(+77.9%) |
| Jun 2019 | - | -$14.03M(+126.9%) | -$20.28M(+224.6%) |
| Mar 2019 | - | -$6.18M(+9413.8%) | -$6.25M(+9513.8%) |
| Sep 2018 | - | -$65.00K | -$65.00K |
FAQ
- What is Mirum Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals annual EBIT year-on-year change?
- What is Mirum Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly EBIT year-on-year change?
- What is Mirum Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals TTM EBIT year-on-year change?
What is Mirum Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of MIRM is -$72.60M
What is the all time high annual EBIT for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high annual earnings before interest & taxes is -$52.53M
What is Mirum Pharmaceuticals annual EBIT year-on-year change?
Over the past year, MIRM annual earnings before interest & taxes has changed by +$74.72M (+50.72%)
What is Mirum Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of MIRM is -$10.05M
What is the all time high quarterly EBIT for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high quarterly earnings before interest & taxes is $61.32M
What is Mirum Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, MIRM quarterly earnings before interest & taxes has changed by +$11.03M (+52.31%)
What is Mirum Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of MIRM is -$61.58M
What is the all time high TTM EBIT for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high TTM earnings before interest & taxes is -$65.00K
What is Mirum Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, MIRM TTM earnings before interest & taxes has changed by +$81.14M (+56.85%)